Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
J Med Case Rep ; 16(1): 293, 2022 Jul 30.
Article in English | MEDLINE | ID: mdl-35906668

ABSTRACT

BACKGROUND: Aggressive angiomyxoma (AAM) is a locally infiltrative mesenchymal tumour that most commonly affects the pelvis and/or perineum in adult women. AAM is very rare in males, especially in infancy. CASE PRESENTATION: A 10-month-old fulani (African) male infant was referred to our department for a large painless mass in the right testicule. The mass was detected during the neonatal period and gradually increased in size. Ultrasound examination revealed a large heterogeneous lesion; computed tomography results led to the conclusion that the mass was a mesenteric hernia. An inguinal and scrotal surgical approach was adopted. Exploratory surgery found a normal right testicle displaced upwardly and a large scrotal mass. Radical excision of the mass and orchidopexy were performed. Subsequent histology and immunohistochemstry studies indicated that the mass was a scrotal angiomyxoma. The postoperative course was uneventful. No recurrence occurred during the 6-month follow-up. CONCLUSION: To the best of our knowledge, this is the youngest patient with AAM reported to date. Angiomyxoma should be included in the differential diagnosis of scrotal masses, for which radical excision is justifiable to prevent recurrence.


Subject(s)
Genital Neoplasms, Male , Myxoma , Adult , Female , Genital Neoplasms, Male/diagnostic imaging , Genital Neoplasms, Male/surgery , Humans , Hypertrophy , Infant , Infant, Newborn , Male , Myxoma/diagnostic imaging , Myxoma/surgery , Perineum/pathology , Perineum/surgery , Scrotum/diagnostic imaging , Scrotum/pathology , Scrotum/surgery , Tomography, X-Ray Computed
2.
J Med Case Rep ; 14(1): 41, 2020 Mar 10.
Article in English | MEDLINE | ID: mdl-32156307

ABSTRACT

BACKGROUND: Neuroendocrine carcinomas mainly affect the bronchopulmonary and the gastrointestinal systems. Breast localizations are very rare. They represent less than 0.1% of all breast cancers. A definitive diagnosis relies on histological and immunohistochemical examinations. CASE PRESENTATION: Case 1 We report a case of primary neuroendocrine carcinoma of the breast in a 71-year-old Arabic woman who presented with a 3 cm palpable and mobile tumor of the right breast. Clinical and radiological assessment excluded any other primary tumor. Radical mastectomy and axillary lymph node resection were performed. A histopathological examination disclosed the diagnosis of primary breast neuroendocrine tumors, with negative surgical margins and lymph nodes (18 N-/18 N). The tumor cells were positive for neuroendocrine markers, a weak Ki-67 proliferation index and negative Her2/neu. Our patient received adjuvant hormonal treatment with anti-aromatase for 21 months. She is on regular follow-up, and she remains free of disease to date. Case 2 A 48-year-old Arabic woman consulted for a right breast nodule. She underwent lumpectomy with right axillary lymphadenectomy. The diagnosis was breast neuroendocrine tumor. Systemic treatment was proposed, but she was lost to follow-up. She consulted 1 year later for a mass in the same breast. A histological and immunohistochemical examination of a mammary biopsy was consistent with a recurrence of the previous neuroendocrine tumor. A radiological assessment showed a large mass in her right breast, ipsilateral axillary lymphadenopathies, and hepatic and pulmonary metastases. She received first-line metastatic chemotherapy, with good clinical and radiological improvement. She refused the mastectomy and was given hormone therapy. One year later, the tumor expanded clinically and radiologically, and she underwent second-line metastatic chemotherapy, with good clinical progress and radiological stability, and she then underwent maintenance hormonal therapy. CONCLUSION: Due to the rarity of primary breast neuroendocrine tumors, no standard therapy exists and the prognosis remains difficult to determine. Studies, including larger series, are needed in order to understand the biological behavior of these tumors.


Subject(s)
Breast Neoplasms/diagnosis , Breast Neoplasms/therapy , Carcinoma, Neuroendocrine/diagnosis , Carcinoma, Neuroendocrine/therapy , Aged , Breast/diagnostic imaging , Breast/pathology , Female , Humans , Liver Neoplasms/secondary , Liver Neoplasms/therapy , Lung Neoplasms/secondary , Lung Neoplasms/therapy , Middle Aged , Neoplasm Recurrence, Local
3.
Pan Afr Med J ; 34: 184, 2019.
Article in French | MEDLINE | ID: mdl-32153723

ABSTRACT

Urothelial carcinoma is usually characterized by severe symptoms including macroscopic haematuria. We here report the case of a female patient without a history of smoking or urothelial carcinoma, making it, to our knowledge, a unique case and a first case of urothelial carcinoma revealed by brain metastasis.


Subject(s)
Brain Neoplasms/pathology , Kidney Calices/pathology , Kidney Neoplasms/diagnosis , Aged , Brain Neoplasms/diagnosis , Female , Hematuria/etiology , Humans , Kidney Neoplasms/pathology , Kidney Neoplasms/secondary
4.
J Med Case Rep ; 11(1): 155, 2017 Jun 12.
Article in English | MEDLINE | ID: mdl-28602157

ABSTRACT

BACKGROUND: Neuroendocrine tumors are a large group of tumors with a wide spectrum of behavior, affecting mainly the digestive system and the lung. The thymus is very rarely affected. CASE PRESENTATION: A 28-year-old Arab woman presented with chronic chest pain and dyspnea. A computed tomography scan showed a huge anterior mediastinal mass invading neighboring structures. A mediastinotomy was performed with biopsies of the mass. Pathological findings were consistent with a thymic large cell neuroendocrine carcinoma. CONCLUSIONS: The occurrence of a large cell neuroendocrine carcinoma in the thymus, especially in young people, is extremely rare. In this current report, we discuss the clinicopathological issues of this rare tumor according to recent literature data.


Subject(s)
Antineoplastic Agents/therapeutic use , Carcinoma, Neuroendocrine/diagnosis , Thymoma/diagnosis , Thymus Neoplasms/diagnosis , Adult , Carcinoma, Neuroendocrine/pathology , Carcinoma, Neuroendocrine/therapy , Chest Pain/etiology , Disease Progression , Dyspnea/etiology , Female , Humans , Thoracic Surgical Procedures , Thymoma/pathology , Thymoma/physiopathology , Thymoma/therapy , Thymus Neoplasms/pathology , Thymus Neoplasms/physiopathology , Thymus Neoplasms/therapy , Tomography, X-Ray Computed , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...